Home » today » Health » Covid-19 : the Discovery of a first treatment in the United Kingdom

Covid-19 : the Discovery of a first treatment in the United Kingdom


The british scientists have found that the steroid dexamethasone may reduce mortality in one third of patients with serious illnesses, those who need assistance to breathe. The WHO stresses that it should only be used under strict medical supervision and not as a preventative treatment. Its experts have also announced the permanent suspension of the search pane on the hydroxychloroquine of the global clinical trial Organization

Friday 19 June 2020 ((rezonodwes.com))– The world health Organization (WHO) has hailed the results of the first clinical trials carried out in the Uk, which show that dexamethasone, a corticosteroid, can save the lives of critically ill patients with the Covid-19.

For patients on respirators, it has been demonstrated that treatment reduced mortality by about a third and for patients requiring oxygen, the mortality has been reduced by about a fifth, according to the preliminary results, reported to the experts.

“However, it has been shown that dexamethasone has no beneficial effect for people with benign diseases, those who are not in need of respiratory assistance “, explained the Director of the organization, Dr Tedros Adhanom Gebreyesus.

Although this is good news for patients with serious illnesses, Dr. Tedros and his team have warned that these drugs should only be used under close medical supervision.

The Director of emergencies at WHO, Michael Ryan, has explained that the dexamethasone is an anti-inflammatory, very powerful.

“This allows patients to continue to receive oxygen from the blood in the lungs by reducing very rapidly the inflammation at a critical time of the disease. It is not a treatment against the virus itself, or a prevention against the virus, ” he said.

Mr. Ryan has also warned that the taking of anticorticoïdes as a preventive measure for the coronavirus might even help the virus to divide and to replicate in the body.

“This drug is reserved only for critical patients who are under respiratory assistance,” said the expert.

The Director of the emergency department has also sent a message to the country, stating that it is not now act so thoughtless after the discovery.

“The workers need training, we need to ensure that we have enough medicines, and we have yet to examine the final data “, he said.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.